Title
Category
Credits
Event date
Cost
Immunogenicity characterization tools (ADAs, complement, immune complexes)
  • Immunosafety
  • 0.50 Participation
$25.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of seven providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting.
Immunopathology: Evaluation from Discovery to Safety Assessment
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of seven providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Tracy Papenfuss at StageBio.
Immunophenotyping
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of six providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Birgit Fogal at Boehringer Ingelheim.
Systems Biology Applied to Immune Safety
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Immuno-Safety Tools module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of six providing detailed information on tools currently used to evaluate and characterize the status of the immune system in a preclinical setting and is led by Dr. Holden Maecker at Stanford University.
CAR Therapy
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics that interact with the immune system and is led by Dr. Cori Abikoff and Dr. Lauren Gauthier at Takeda Pharmaceuticals.
Safety Considerations for Oligonucleotides
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics that interact with the immune system and is led by Dr. Padmakumar Narayanan at WAVE Life Sciences.
CD3-binding (T cell engaging) immune stimulating antibody-based therapies
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics that interact with the immune system and is led by Dr. Benno Rattel at AMGEN.
Gene Therapy
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics that interact with the immune system and is led by Dr. Kathleen Meyer at Sangamo Therapeutics.
Nonclinical Development of Biologics
  • Immunosafety
  • 1.00 Participation
$35.00
Welcome!We are delighted that you have chosen the Therapeutic Modalities module to start or enhance your current educational journey in immuno-safety science. This lecture is one in a series of five providing detailed information on current and/or emerging therapeutics that interact with the immune system and is led by Dr. Melanie Hartsough of Hartsough Nonclinical Consulting.